Raymond James Financial Inc. acquired a new position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 244,854 shares of the construction company's stock, valued at approximately $2,909,000. Raymond James Financial Inc. owned 0.30% of Aspen Aerogels at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. AlphaQuest LLC lifted its stake in shares of Aspen Aerogels by 54.0% in the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after purchasing an additional 3,998 shares during the period. KLP Kapitalforvaltning AS purchased a new position in Aspen Aerogels during the fourth quarter valued at $164,000. Journey Strategic Wealth LLC bought a new stake in shares of Aspen Aerogels during the 4th quarter valued at $178,000. Ballentine Partners LLC grew its position in shares of Aspen Aerogels by 19.2% in the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock worth $189,000 after buying an additional 2,565 shares during the period. Finally, Capula Management Ltd bought a new position in shares of Aspen Aerogels in the 4th quarter worth about $208,000. 97.64% of the stock is owned by institutional investors.
Analyst Ratings Changes
ASPN has been the topic of a number of recent research reports. Barclays cut their price objective on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a report on Wednesday, February 19th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. Craig Hallum lowered their price objective on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research note on Friday, February 14th. B. Riley dropped their target price on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a report on Wednesday, February 19th. Finally, Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Aspen Aerogels has a consensus rating of "Moderate Buy" and an average target price of $19.11.
Read Our Latest Stock Report on ASPN
Aspen Aerogels Stock Performance
Shares of NYSE ASPN traded up $0.27 during trading on Friday, reaching $5.82. 1,469,753 shares of the company traded hands, compared to its average volume of 1,884,985. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm has a 50 day simple moving average of $6.30 and a 200-day simple moving average of $11.08. Aspen Aerogels, Inc. has a 52-week low of $4.80 and a 52-week high of $33.15. The stock has a market capitalization of $477.85 million, a PE ratio of 36.38 and a beta of 2.72.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Equities research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.
Aspen Aerogels Company Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
See Also

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.